genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Jakafi Success Helps Incyte Land Blockbuster MorphoSys Partnership
GEN Edge
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Cellular Therapeutics
From J.P. Morgan: Cell, Gene Therapy to Drive Biopharma M&A in…
GEN Edge
AGTC Plans Pivotal Trial for XLRP Gene Therapy
GEN Edge
TwinStrand’s Duplex Sequencing Goes Deep
News
News
Cells Huddle to Cope with Stress, Defy Cancer Meds
Commentary
Notes and Takeaways from JPM 2020
News
ELOVL2 Gene Found to Play Critical Role in Aging of the…
Genetics
Molecular Bridge Found for ALS Genes
Neuroscience
Decision Making Visualized in Zebrafish Larva, Points to Surprising Role for…
Insights
All
Trends for 2020
ALS
Neurodegenerative Treatments Build to a Tipping Point
Insights
Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures
Insights
Learning to Speak Genome
Brexit
Ensuring the Security of Supply for Brexit
A-Lists
Insights
Top 10 Young Companies in the Money, 2019
January 2020 Vol. 40 No. 1
8 Biopharma Trends to Watch in 2020
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Cells Huddle to Cope with Stress, Defy Cancer Meds
Commentary
Notes and Takeaways from JPM 2020
News
ELOVL2 Gene Found to Play Critical Role in Aging of the…
ALS
Neurodegenerative Treatments Build to a Tipping Point
Magazine
Artificial Intelligence
The Outlook for 2020 and Beyond
January 2020 Vol. 40 No. 1
Super-Resolution Microscopy Comes into Focus
January 2020 Vol. 40 No. 1
Biopharma’s Lab of the Future Can’t Wait
January 2020 Vol. 40 No. 1
Convergence Fends Off Malthus
January 2020 Vol. 40 No. 1
From CRISPR Multiplexing to Pleistocene Park
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
Find the Right Fit when Tackling Late Stage Bioprocessing Challenges
Upcoming Webinars
Get Fired Up about Multiplexed Biomarker Profiling
Upcoming Webinars
Designing Next-Generation Regulatory T Cell Therapies with Single-Cell Proteomics
January 2020 Vol. 40 No. 1
Experimental Program Design Considerations for Optimized Use of Preclinical Models in…
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Cellular Therapeutics
Cellular Therapeutics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cellular Therapeutics
From J.P. Morgan: Cell, Gene Therapy to Drive Biopharma M&A in 2020
Cellular Therapeutics
Vertex Expanding into Diabetes Cell Therapy with Plans to Acquire Semma
Cellular Therapeutics
BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B Financing
Cellular Therapeutics
Cancer-Killing T Cells Subdued, Kept “Stemmy,” by Potassium
Cellular Therapeutics
Israel’s Sheba Medical Center to Manufacture Cell Therapies Using Lonza’s Cocoon Platform
Cellular Therapeutics
Cancer Spread and Blood Clots May Be Halted by Platelet Decoys
Cellular Therapeutics
Capricor Axes About Half Its Workforce, Resumes Dosing in Trial of...
Cellular Therapeutics
Cell Therapy Manufacturing: The Supply Chain Challenge
Cellular Therapeutics
Conjoined Cells Form a Potent Immunotherapy Combo
Cellular Therapeutics
GE Healthcare, Swedish Government Open an Innovation Center in Uppsala
Cellular Therapeutics
Astellas Expands Its Eye Disorder Pipeline with Quethera Purchase
Cellular Therapeutics
Torque Unveils Manufacturing Platform for Its “Deep Primed” T-Cell Cancer Therapies
Cellular Therapeutics
Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition
Cellular Therapeutics
Teratoma-Derived Stem Cells Rebuild Muscle in Model of Muscular Dystrophy
Cellular Therapeutics
CRISPR “One Shot” Cell Therapy for Hemophilia Developed
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; }
![Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]](https://www.genengnews.com/wp-content/uploads/2018/08/ENTrIA_recognition_EN_without_entria1024x9291472362223-324x160.png "Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition")
